Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 645.6K | $4.0M | 9.52% | -- | 2026-06-30 |
| Vivo Capital, LLC | 292.7K | $2.0M | 4.32% | -- | 2026-06-30 |
| UBS Group AG | 177.4K | $1.0M | 2.62% | +171.0K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 163.7K | $1.0M | 2.41% | -10.8K | 2026-06-30 |
| MILLENNIUM MANAGEMENT LLC | 134.6K | $1.0M | 1.98% | +1.6K | 2026-06-30 |
| Kalehua Capital Management LLC | 99.6K | -- | 1.47% | -40.2K | 2026-06-30 |
| BlackRock, Inc. | 55.5K | -- | 0.82% | +3.5K | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 50.3K | -- | 0.74% | -8.8K | 2026-06-30 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 50.0K | -- | 0.74% | -- | 2026-06-30 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 43.1K | -- | 0.63% | -- | 2026-06-30 |
